Phenotology of disease-linked proteins

Human Mutation

Volumn 25, Issue 1, 2005, Pages 90-97

  Myers, Jeffrey K ^a   Beihoffer, Lauren A ^a   Sanders, Charles R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disease mutation; GPCR; Ion channel; Peripheral myelin protein 22; Phenotype; PMP22; Rhodopsin; Vasopressin receptor

Indexed keywords

DNA; G PROTEIN COUPLED RECEPTOR; VOLTAGE GATED POTASSIUM CHANNEL;

ARTICLE; DATA BASE; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; MISSENSE MUTATION; MUTATION RATE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; STATISTICAL SIGNIFICANCE;

AMINO ACID SEQUENCE; GENETIC DISEASES, INBORN; GENETIC MARKERS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; PHENOTYPE; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE ALIGNMENT;

EID: 11344280896     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.20118     Document Type: Article

References (44)

1. Alewijnse AE, Timmerman H, Jacobs EH, Smit MJ, Roovers E, Cotecchia S, Leurs R. 2000. The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol Pharmacol 57:890-898.
2. Andres A, Kosoy A, Garriga P, Manyosa J. 2001. Mutations at position 125 in transmembrane helix III of rhodopsin affect the structure and signalling of the receptor. Eur J Biochem 268:5696-5704.
3. Arora KK, Cheng Z, Catt KJ. 1997. Mutations of the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol Endocrinol 11:1203-1212.
4. Barak LS, Menard L, Ferguson SS, Colapietro AM, Caron MG. 1995. The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. Biochemistry 34:15407-15414.
5. Barlow DJ, Thornton JM. 1988. Helix geometry in proteins. J Mol Biol 201:601-619.
6. Botstein D, Risch N. 2003. Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nat Genet 33(Suppl):228-237.
7. Brandl CJ, Deber CM. 1986. Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc Natl Acad Sci USA 83:917-921.
8. Caron P, Chauvin S, Christin-Maitre S, Bennet A, Lahlou N, Counis R, Bouchard P, Kottler ML. 1999. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 84:990-996.
9. Ciccarelli FD, Acciarito A, Alberti S. 2000. Large and diverse numbers of human diseases with HIKE mutations. Hum Mol Genet 9:1001-1007.
10. Cooper DN, Krawczak M. 1990. The mutational spectrum of single base-pair substitutions causing human genetic disease: patterns and predictions. Hum Genet 85:55-74.
11. Dobson CM. 2003. Protein folding and misfolding. Nature 426:884-890.
12. Edvardsen O, Reiersen AL, Beukers MW, Kristiansen K. 2002. tGRAP, the G-protein coupled receptors mutant database. Nucleic Acids Res 30:361-363.
13. Edwards SW, Tan CM, Limbird LE. 2000. Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol Sci 21:304-308.
14. Filipek S, Teller DC, Palczewski K, Stenkamp R. 2003. The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors. Annu Rev Biophys Biomol Struct 32:375-397.
15. Forloni G, Terreni L, Bertani I, Fogliarino S, Invernizzi R, Assini A, Ribizzi G, Negro A, Calabrese E, Volonte MA, Mariani C, Franceschi M, Tabaton M, Bertoli A. 2002. Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms. Neurobiol Aging 23:957-976.
16. Fredriksson R, Lagerstrom MC, Lundin LG, Schioth HB. 2003. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol Pharmacol 63:1256-1272.
17. Fritze O, Filipek S, Kuksa V, Palczewski K, Hofmann KP Ernst OP. 2003. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation. Proc Natl Acad Sci USA 100:2290-2295.
18. Garriga P, Liu X, Khorana HG. 1996. Structure and function in rhodopsin: correct folding and misfolding in point mutants at and in proximity to the site of the retinitis pigmentosa mutation Leu-125-> Arg in the transmembrane helix C. Proc Natl Acad Sci USA 93:4560-4564.
19. Horn F, Vriend G, Cohen FE. 2001. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res 29:346-349.
20. Jiang Y, Lee A, Chen J, Ruta V, Cadene M, Chait BT, MacKinnon R. 2003. X-ray structure of a voltage-dependent K+ channel. Nature 423:33-41.
21. Kaushal S, Khorana HG. 1994. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33:6121-6128.
22. Kopp P. 2001. The TSH receptor and its role in thyroid disease. Cell Mol Life Sci 58:1301-1322.
23. Kosugi S, Hai N, Okamoto H, Sugawa H, Mori T. 2000. A novel activating mutation in the thyrotropin receptor gene in an autonomously functioning thyroid nodule developed by a Japanese patient. Eur J Endocrinol 143:471-477.
24. Krawczak M, Ball EV, Cooper DN. 1998. Neighboring-nucleotide effects on the rates of germ-line sihgle-base-pair substitution in human genes. Am J Hum Genet 63:474-488.
25. Letts VA, Felix R, Biddlecome GH, Arikkath J, Mahaffey CL, Valenzuela A, Bartlett FS, Mori Y, Campbell KP, Frankel WN. 1998. The mouse stargazer gene encodes a neuronal Ca2+ channel gamma subunit. Nat Genet 19:340-347.
26. Miller MP, Kumar S. 2001. Understanding human disease mutations through the use of interspecific genetic variation. Hum Mol Genet 10:2319-2328.
27. Mirzadegan T, Benko G, Filipek S, Palczewski K. 2003. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. Biochemistry 42:2759-2767.
28. Morello JP, Bichet DG. 2001. Nephrogenic diabetes insipidus. Annu Rev Physiol 63:607-630.
29. Okada T, Fujiyoshi Y, Silow M, Navarro J, Landau EM, Shichida Y. 2002. Functional role of internal water molecules in rhodopsin revealed by X-ray crystallography. Proc Natl Acad Sci USA 99:5982-5987.
30. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le TI, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M. 2000. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289:739-745.
31. Rana BK, Shiina T, Insel PA. 2001. Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications. Annu Rev Pharmacol Toxicol 41:593-624.
32. Russo D, Tumino S, Arturi F, Vigneri P Grasso G, Pontecorvi A, Filetti S, Belfiore A. 1997. Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 82:735-738.
33. Sanders CR, Ismail-Beigi F, McEnery MW. 2001. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins. Biochemistry 40:9453-9459.
34. Sanders CR, Myers JK. 2004. Disease-related misassembly of membrane proteins. Annu Rev Biophys Biomol Struct 33:25-51.
35. Scheer A, Fanelli F, Costa T, De Benedetti PG, Cotecchia S. 1996. Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J 15:3566-3578.
36. Shenker A. 2002. Activating mutations of the lutropin choriogonadotropin receptor in precocious puberty. Receptors Channels 8:3-18.
37. Stenson PD, Ball EV Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN. 2003. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 21:577-581.
38. Stevens FJ, Pokkuluri PR, Schiffer M. 2000. Protein conformation and disease: pathological consequences of analogous mutations in homologous proteins. Biochemistry 39:15291-15296.
39. Stojanovic A, Hwa J. 2002. Rhodopsin and retinitis pigmentosa: shedding light on structure and function. Receptors Channels 8:33-50.
40. Stojanovic A, Hwang I, Khorana HG, Hwa J. 2003. Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis. J Biol Chem 278:39020-39028.
41. Suel GM, Lockless SW, Wall MA, Ranganathan R. 2003. Evolutionarily conserved networks of residues mediate allosteric communication in proteins. Nat Struct Biol 10:59-69.
42. Teller DC, Okada T, Behnke CA, Palczewski K, Stenkamp RE. 2001. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). Biochemistry 40:7761-7772.
43. Wenkert D, Merendino JJ Jr, Shenker A, Thambi N, Robertson GL, Moses AM, Spiegel AM. 1994. Novel mutations in the V2 vasopressin receptor gene of patients with X-linked nephrogenic diabetes insipidus. Hum Mol Genet 3:1429-1430.
44. Wigley WC, Corboy MJ, Cutler TD, Thibodeau PH, Oldan J, Lee MG, Rizo J, Hunt JF, Thomas PJ. 2002. A protein sequence that can encode native structure by disfavoring alternate conformations. Nat Struct Biol 9:381-388.